Payload– tag –
-
LandSpace Achieves China’s First Ground-Controlled Booster Recovery with Zhuque-3 Rocket, Advancing Reusability
Tech Trends (South China Morning Post) China Overview Chinese private aerospace firm LandSpace successfully executed China's first ground-controlled recovery of its Zhuque-3 rocket booster in August 2026, utilizing landing legs akin to S... -
Rocket Lab Successfully Launches 16th Mission of the Year, Deploying Earth Observation Satellite for Undisclosed Customer
Space.com New Zealand Overview Rocket Lab successfully launched an Earth observation satellite for an undisclosed customer on September 10, 2026, marking its 16th mission of the year. The 'Happily Ever Faster' mission utilized an Electro... -
Inversion Awarded NASA Contract to Advance Aerocapture Technology for Mars, Uranus, and Neptune Missions Using Arc Spacecraft
PR Newswire USA Overview Inversion has secured a NASA contract to study aerocapture demonstration using its Arc spacecraft, aiming to mature the technology for future interplanetary missions such as Mars telecommunications satellites and... -
FDA Approves Multiple Novel Cancer Therapeutics, Including Multi-Selective RAS(ON) Inhibitor Daraxonrasib and Next-Gen ADCs for Difficult-to-Treat Cancers
The ASCO Post USA Overview The U.S. FDA announced several groundbreaking cancer drug approvals on September 10, 2026, including daraxonrasib, a multi-selective RAS(ON) inhibitor, for metastatic pancreatic adenocarcinoma. Other approvals ... -
OS Therapies Strengthens FDA & MHRA Alignment, Joins Project Orbis for OST-HER2 Metastatic Osteosarcoma Program
OS Therapies USA Overview OS Therapies announced strengthened alignment with the FDA and MHRA and approval to join Project Orbis for its lead candidate, OST-HER2 (a next-generation tunable ADC) program for metastatic osteosarcoma. Projec... -
WuXi XDC Out-Licenses WuXiTecan-2 Linker-Payload Technology to Ona Therapeutics to Accelerate ADC Development
PR Newswire China Overview WuXi XDC announced the out-licensing of its innovative WuXiTecan-2 linker-payload technology platform to Ona Therapeutics, a Spanish biotechnology company, to advance novel Antibody-Drug Conjugate (ADC) researc... -
Shilpa Biologicals Opens GMP Facility for ADC Manufacturing in India’s Pharmacit
Biospectrum Jobs India Overview Shilpa Biologicals has inaugurated a new GMP-compliant facility in Pharmacit, India, dedicated to the manufacturing of Antibody-Drug Conjugates (ADCs). This state-of-the-art facility will provide end-to-en... -
Akeso’s EGFR/TROP2 Bispecific ADC AK158D1 Cleared for Phase I Clinical Trial in Advanced Solid Tumors by China’s NMPA
PR Newswire China Overview Akeso Inc., a Chinese biopharmaceutical company, announced that its EGFR and TROP2 bispecific antibody-drug conjugate (ADC) candidate, AK158D1, has received clearance from China's National Medical Products Admi... -
Varda Space Industries Expands In-Orbit Pharmaceutical Manufacturing and Reentry Capsule Operations for Advanced Missions and Higher Cadence
Stock Analysis USA Overview Varda Space Industries is rapidly expanding its business in microgravity pharmaceutical manufacturing and the development of reentry capsules to safely return products to Earth. The company is actively scaling... -
Morehead State University’s Lunar Environment Monitoring Station (LEMS) Approved for NASA Artemis Moon Mission
Morehead State University USA Overview NASA has formally accepted Morehead State University's Lunar Environment Monitoring Station (LEMS) for flight on an upcoming Artemis mission to the lunar surface. LEMS, a compact autonomous station ...
